Advertisement

Picture EBD Group BioPharm America 2019 Boston September 600x60px
Document › Details

Medigene AG. (8/3/12). "Press Release: Medigene Reports Positive Financial Results and Pipeline Progress for the First Six Months of 2012". Martinsried.

Organisations Organisation Medigene AG (FSE: MDG1, Prime Standard)
  Group Medigene (Group)
  Organisation 2 Astellas (Group)
Products Product EndoTAG™-1
  Product 2 RhuDex®
  Index term 2 Astellas–Medigene: leuprolide, 201007–2011 product acquisition €25m transfer of rights to Eligard to Astellas
Persons Person Mathias, Frank (Rentschler 201604– CEO before Medigene + Amgen GmbH + Servier DE + Hoechst)
  Person 2 Christ, Arnd (InflaRx 201506– CFO before Proteros + MediGene + NovImmune + Probiodrug + Hoechst)
     


   
Record changed: 2019-06-09

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

More documents for Medigene (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group BioPharm America 2019 Boston September 600x60px




» top